Page last updated: 2024-11-12

potassium cyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

potassium cyanate: RN given refers to cpd with MF of K-CHNO [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11378442
CHEMBL ID4079232
CHEBI ID38904
MeSH IDM0083476

Synonyms (57)

Synonym
AKOS015833743
ai3-28750
kaliumcyanat [german]
epa pesticide chemical code 068002
d&p double o crabgrass killer
einecs 209-676-3
caswell no. 688
hsdb 1757
nsc 146178
nsc-146178
cyanic acid, potassium salt
weedanol cyanol
weedone crab grass killer
green cross crabgrass killer
aero cyanate
kaliumcyanat
potassium isocyanate
p.c. 80 crabgrass killer
miller p.c. weedkiller
ded-weed crabgrass killer
bulpur
dupont pc crabgrass killer
potassium cyanate (kcno)
potassium cyanate (kocn)
alicyanate
590-28-3
bonide krab crabgrass killer
aero cyanate weedkiller
d & p double o crabgrass killer
kocn
kaliumzyanat
CHEBI:38904
potassium cyanate
FT-0659644
C19067
ckno
isocyanic acid potassium salt
cyanic acid, potassium salt (1:1)
ec 209-676-3
g9c31twn5m ,
unii-g9c31twn5m
potassiumcyanate
potassium cyanate [hsdb]
potassium cyanate [mi]
potassium cyanate [inci]
DTXSID2047692
GKKCIDNWFBPDBW-UHFFFAOYSA-M
potassium-cyanate
5-nitrobarbituricacidtrihydrate
SY006099
mfcd00011411
Q416304
590-23-8
potassium;cyanate
D78243
CHEMBL4079232
CS-0017815

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The potential for widespread human inhalation exposure to this toxic gas is recognized as a public health concern."( Changes in intracellular pH play a secondary role in hydrogen sulfide-induced nasal cytotoxicity.
Dorman, DC; Lancianese, S; Marshall, MW; McManus, BE; Roberts, ES; Wong, VA, 2006
)
0.33
" Accordingly, a direct toxicity assessment (DTA) based on chronoamperometry was proposed to detect the effect of toxic chemicals on microorganisms."( Direct toxicity assessment of toxic chemicals with electrochemical method.
Dong, S; Liu, C; Sun, T; Xu, X, 2009
)
0.35
"It is difficult task to measure precisely the toxic effect of beta-amyloid (Aβ 1-42) peptides and also the protective effect of novel drug candidates against Aβ-peptides."( A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays.
Datki, Z; Hunya, A; Mozes, E; Penke, B; Posa, A, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
herbicideA substance used to destroy plant pests.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
cyanate salt
one-carbon compoundAn organic molecular entity containing a single carbon atom (C1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1429985Inhibition of MDR1 in human COLO320/MDR-LRP cells assessed as rhodamine-123 accumulation measured as fluorescence activity ratio at 20 uM preincubated for 10 mins followed by rhodamine-123 addition measured after 20 mins by flow cytometry (Rvb = 0.53 to 02017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429989Cytotoxicity against multidrug resistant human COLO320 cells after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429991Cytotoxicity against human MRC5 cells after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429987Inhibition of MDR1 in human COLO320/MDR-LRP cells assessed as rhodamine-123 accumulation measured as fluorescence activity ratio quotient at 20 uM preincubated for 10 mins followed by rhodamine-123 addition measured after 20 mins by flow cytometry relativ2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429984Inhibition of MDR1 in human COLO320/MDR-LRP cells assessed as rhodamine-123 accumulation measured as fluorescence activity ratio at 2 uM preincubated for 10 mins followed by rhodamine-123 addition measured after 20 mins by flow cytometry (Rvb = 0.53 to 0.2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429994Induction of apoptosis in human COLO320 cells assessed as early apoptotic cells at 2 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 20.3%)2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429986Inhibition of MDR1 in human COLO320/MDR-LRP cells assessed as rhodamine-123 accumulation measured as fluorescence activity ratio quotient at 2 uM preincubated for 10 mins followed by rhodamine-123 addition measured after 20 mins by flow cytometry relative2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429988Cytotoxicity against doxorubicin-sensitive human COLO205 cells after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429995Induction of apoptosis in human COLO320 cells assessed as late apoptotic/necrotic cells at 2 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 9.93%)2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1429996Induction of apoptosis in human COLO320 cells assessed as cell death at 2 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 4.75%)2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
AID1430000Induction of apoptosis in human COLO320 cells at 2 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry relative to M6272017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (109)

TimeframeStudies, This Drug (%)All Drugs %
pre-199038 (34.86)18.7374
1990's27 (24.77)18.2507
2000's25 (22.94)29.6817
2010's15 (13.76)24.3611
2020's4 (3.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.77 (24.57)
Research Supply Index4.75 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index64.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.88%)5.53%
Reviews3 (2.63%)6.00%
Case Studies1 (0.88%)4.05%
Observational0 (0.00%)0.25%
Other109 (95.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]